Cargando…
Detection and quantification of beta cells by PET imaging: why clinical implementation has never been closer
In this issue of Diabetologia, Alavi and Werner (10.1007/s00125-018-4676-1) criticise the attempts to use positron emission tomography (PET) for in vivo imaging of pancreatic beta cells, which they consider as ‘futile’. In support of this strong statement, they point out the limitations of PET imagi...
Autores principales: | Gotthardt, Martin, Eizirik, Decio L., Aanstoot, Henk-Jan, Korsgren, Olle, Mul, Dick, Martin, Frank, Boss, Marti, Jansen, Tom J. P., van Lith, Sanne A. M., Buitinga, Mijke, Eriksson, Olof, Cnop, Miriam, Brom, Maarten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223852/ https://www.ncbi.nlm.nih.gov/pubmed/30284016 http://dx.doi.org/10.1007/s00125-018-4745-5 |
Ejemplares similares
-
Exendin‐4 analogs in insulinoma theranostics
por: Jansen, Tom.J.P., et al.
Publicado: (2019) -
ER and vacuoles: never been closer
por: Viotti, Corrado
Publicado: (2014) -
Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
por: Boss, Marti, et al.
Publicado: (2020) -
Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW
por: Boss, Marti, et al.
Publicado: (2020) -
PET-Based Human Dosimetry of (68)Ga-NODAGA-Exendin-4, a Tracer for β-Cell Imaging
por: Boss, Marti, et al.
Publicado: (2020)